New therapies to improve the lives of patients with hyperhidrosis

New therapies to improve the lives of patients with hyperhidrosis

TheraVida is a Chapel Hill, North Carolina based clinical stage specialty pharmaceutical company focused on the development of Anhydrix™

TheraVida is dedicated to the development of new therapies to improve the lives of patients with hyperhidrosis.

Using a unique and patent-protected combination drug technology, we are developing a pharmaceutical product with an improved tolerability profile relative to existing therapies. Our technology has been shown in initial clinical trials to deliver this benefit without sacrificing efficacy.

Our lead combination drug product, Anhydrix™, has successfully completed a phase 2 human study for the treatment of primary focal hyperhidrosis.

About Us

TheraVida is a Chapel Hill, North Carolina based clinical stage specialty pharmaceutical company focused on … Read More

Therapeutic Focus

Primary focal hyperhidrosis is a chronic disorder of an abnormally high amount of perspiration which is… Read More

Technology

TheraVida has developed a proprietary and patent-protected product, where a positive-acting agent… Read More

Hyperhidrosis Overview

Primary focal hyperhidrosis is a chronic disorder of an abnormally high amount of perspiration which is in excess of that required for natural thermal regulation.